News

Filter

Current filters:

None

10 to 19 of 97930 results

WHO reports launch of Merck/NewLink VSV-EBOV vaccine trial in Guinea

WHO reports launch of Merck/NewLink VSV-EBOV vaccine trial in Guinea

06-03-2015

The World Health Organization has reported the launch trials of the VSV-EBOV vaccine for Ebola in Guinea,…

Anti-viralsGuineaMerck & CoNewLink GeneticsPharmaceuticalResearchVSV-EBOV

AOP Orphan updates on Phase III trial PROUD-PV applying ropeginterferon

06-03-2015

Austria-based rare diseases specialist AOP Orphan Pharmaceuticals has completed recruitment for its Phase…

AOP Orphan PharmaceuticalsBiotechnologyPharmaEssentiaRare diseasesResearchropeginterferon alfa 2b

Japan Pharma outlook 2015

Japan Pharma outlook 2015

06-03-2015

The new pricing system adopted in Japan from April 2014 is a game changer initiative. It pains most of…

BiosimilarsGenericsJapanMarkets & MarketingPricing

Mallinckrodt to expand hospital growth platform with Ikaria acquisition

05-03-2015

US drugmaker Mallinckrodt has entered into an agreement to acquire Ikaria, a privately-held critical…

IkariaInomaxMallinckrodtMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Eisai and Merck enter cancer research collaboration

05-03-2015

Japanese drug major Eisai saw its shares gain 7.15% to 6,732 yen after it announced it had entered into…

EisaiHalavenKeytrudaLenvimaMerck & CoOncologyPharmaceuticalResearch

Norgine partners with Navidea for Lymphoseek marketing in Europe

05-03-2015

Netherlands-headquartered independent drugmaker Norgine says that its affiliate, SpePharm AG, has entered…

BiotechnologyEuropeLicensingLymphoseekNavidea BiopharmaceuticalsNorgineOncology

TWi Pharmaceuticals appoints Tina Guilder as president and chief executive

TWi Pharmaceuticals appoints Tina Guilder as president and chief executive

05-03-2015

Taiwanese pharma company Twi Pharmaceuticals has appointed Tina Guilder as president and chief executive…

BoardroomPharmaceuticalTaiwanTina GuilderTWi Pharmaceuticals

US biosimilar approvals poised to grow, but market uptake faces challenges, says Tufts CSDD

05-03-2015

Biosimilar approvals in the USA are expected to increase during the next five years, but safety concerns…

BiosimilarsBiotechnologyFinancialMarkets & MarketingRegulationUSA

10 to 19 of 97930 results

COMPANY SPOTLIGHT

Menarini

Back to top